PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $552,164 | +562.9% | 276,082 | +596.0% | 0.00% | – |
Q1 2023 | $83,296 | -34.1% | 39,665 | -57.0% | 0.00% | – |
Q4 2022 | $126,340 | +54.1% | 92,219 | +17.5% | 0.00% | – |
Q3 2022 | $82,000 | -9.9% | 78,476 | -6.1% | 0.00% | – |
Q2 2022 | $91,000 | -40.9% | 83,556 | -42.5% | 0.00% | – |
Q1 2022 | $154,000 | +116.9% | 145,208 | +69.5% | 0.00% | – |
Q4 2021 | $71,000 | -79.8% | 85,658 | -67.7% | 0.00% | – |
Q3 2021 | $352,000 | -55.6% | 265,249 | -36.1% | 0.00% | – |
Q2 2021 | $792,000 | +80.4% | 414,965 | +321.2% | 0.00% | – |
Q1 2021 | $439,000 | +442.0% | 98,528 | +343.5% | 0.00% | – |
Q4 2020 | $81,000 | +42.1% | 22,218 | +51.5% | 0.00% | – |
Q3 2020 | $57,000 | -89.5% | 14,661 | -89.8% | 0.00% | – |
Q2 2020 | $542,000 | +337.1% | 143,821 | +185.6% | 0.00% | – |
Q1 2020 | $124,000 | +18.1% | 50,352 | +53.4% | 0.00% | – |
Q4 2019 | $105,000 | – | 32,824 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,413,487 | $2,513,000 | 0.04% |
CAPITAL PERFORMANCE ADVISORS LLP | 25,974 | $27,000 | 0.02% |
MEITAV INVESTMENT HOUSE LTD | 244,332 | $256,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,790 | $139,000 | 0.00% |
IHT Wealth Management, LLC | 22,000 | $23,000 | 0.00% |
Psagot Value Holdings Ltd. / (Israel) | 6,000 | $6,000 | 0.00% |
Smith Salley Wealth Management | 12,048 | $13,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 3,027 | $3,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
DAVENPORT & Co LLC | 22,000 | $23,000 | 0.00% |